Answers are grounded in this paper and cite their sources.
Drug-loaded microneedles have emerged as an important alternative to traditional injection administration. 3D bioprinting technology, with its advantages of customization, provides a new route for the fabrication of microneedles. However, current drug-loaded microneedles still face several key issues, including matched-degree between materials and drug, the impact of manufacturing processes on drug activity, the safety evaluation of complex structures, and barriers to clinical translation. This review systematically summarizes the latest research progress in 3D-bioprinted drug-loaded microneedles, focusing on four aspects material selection, fabrication processes, structural design, and functional applications with clinical translation. Finally, this review provides an outlook on the drug loading capacity, the closed-loop drug release mechanisms, and the clinical standards for microneedles. This paper aims to provide a comprehensive reference for the development of 3D-bioprinted drug-loaded microneedles and to promote their clinical translation and application expansion in the field of drug delivery.
No takes yet. Share an insight, caveat, or question.
Jia et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: